Novilytic Revenue and Competitors
Estimated Revenue & Valuation
- Novilytic's estimated annual revenue is currently $3.5M per year.
- Novilytic's estimated revenue per employee is $388,889
Employee Data
- Novilytic has 9 Employees.
- Novilytic grew their employee count by 0% last year.
Novilytic's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder & Technical Counsel | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | Marketing Director | Reveal Email/Phone |
4 | Director Process Technology | Reveal Email/Phone |
5 | Chief Technology Officer | Reveal Email/Phone |
6 | Chief Operating Officer | Reveal Email/Phone |
7 | Director Analytics | Reveal Email/Phone |
8 | Director Product Management | Reveal Email/Phone |
9 | Product Marketing Specialist | Reveal Email/Phone |
10 | Staff Scientist | Reveal Email/Phone |
Novilytic Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $3.5M | 37 | 16% | N/A | N/A |
#2 | $15M | 88 | 5% | N/A | N/A |
#3 | N/A | 161 | 28% | N/A | N/A |
#4 | N/A | 119 | 43% | N/A | N/A |
#5 | N/A | 46 | 31% | N/A | N/A |
#6 | N/A | 7 | 75% | N/A | N/A |
#7 | $3.5M | 9 | 0% | N/A | N/A |
#8 | N/A | 307 | 63% | N/A | N/A |
What Is Novilytic?
Novilytic is a biochemistry analytics company that protects and secures lifesaving drugs and medical devices. The company is backed by: >25 patents Partnerships: $2B Analytical Instrument Co. 2 Pharmaceutical Consortiums 2 Med & Analytical Universities Our potency is extended by our people which includes 5 Ph.D. Chemists and Engineers who have helped us secure significant patents and other IP. Our business plan will increase those forces to ensure we meet customer, market, and regulatory demands. The Novilytic Product Lines complete the balance of Novilytic’s strength. They include: The Proteometer™ - Disruptive Instrument for pharmaceutical processing NoviChrom™ Analytical Columns Consumables for the Proteometer NoviQuest™ & NoviMASC Reagents Consumables for the Proteometer Novilytic is pursuing Seed Funding to bring the Proteometer to market. With significant strategic advantages, patents, and other IP, Novilytic is expected to experience significant growth over the next 3-4 years.
keywords:N/AN/A
Total Funding
9
Number of Employees
$3.5M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.1M | 9 | -55% | N/A |
#2 | $0.9M | 10 | N/A | N/A |
#3 | $1.3M | 11 | 0% | N/A |
#4 | $1M | 11 | -8% | N/A |
#5 | $1M | 11 | -8% | N/A |